191 related articles for article (PubMed ID: 6698768)
1. Bridging hepatic necrosis in acute viral hepatitis.
Wiener M; Enat R; Gellei B; Barzilai D
Isr J Med Sci; 1984 Jan; 20(1):33-6. PubMed ID: 6698768
[TBL] [Abstract][Full Text] [Related]
2. A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis.
Ware AJ; Cuthbert JA; Shorey J; Gurian LE; Eigenbrodt EH; Combes B
Gastroenterology; 1981 Feb; 80(2):219-24. PubMed ID: 7004995
[TBL] [Abstract][Full Text] [Related]
3. The clinical course of subacute hepatic necrosis.
Theodor E; Niv Y
Am J Gastroenterol; 1978 Dec; 70(6):600-6. PubMed ID: 742611
[TBL] [Abstract][Full Text] [Related]
4. The liver during and after fulminant hepatitis.
Horney JT; Galambos JT
Gastroenterology; 1977 Oct; 73(4 Pt 1):639-45. PubMed ID: 892367
[TBL] [Abstract][Full Text] [Related]
5. Acute viral hepatitis with bridging hepatic necrosis. An overview.
Nisman RM; Ganderson AP; Vlahcevic ZR; Gregory DH
Arch Intern Med; 1979 Nov; 139(11):1289-91. PubMed ID: 508026
[TBL] [Abstract][Full Text] [Related]
6. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
[TBL] [Abstract][Full Text] [Related]
7. Significance of suspected "chronic aggressive hepatitis" in acute hepatitis.
Fauerholdt L; Asnaes S; Ranek L; Schiodt T; Tygstrup N
Gastroenterology; 1977 Sep; 73(3):543-8. PubMed ID: 892354
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of subacute hepatic necrosis in acute hepatitis.
Ware AJ; Eigenbrodt EH; Combes B
Gastroenterology; 1975 Mar; 68(3):519-24. PubMed ID: 1112453
[TBL] [Abstract][Full Text] [Related]
9. [The role of liver biopsy in the diagnosis of autoimmune hepatitis].
Szabó Z
Orv Hetil; 2006 Sep; 147(35):1697-702. PubMed ID: 17051746
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis and pathogenesis of clinical variants in viral hepatitis.
Boyer JL
Am J Clin Pathol; 1976 May; 65(5 Suppl):898-908. PubMed ID: 802749
[TBL] [Abstract][Full Text] [Related]
11. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis).
Boyer JL; Klatskin G
N Engl J Med; 1970 Nov; 283(20):1063-71. PubMed ID: 4319402
[No Abstract] [Full Text] [Related]
12. Role of autoimmunity in nonviral chronic liver disease.
Amarapurkar DN; Amarapurkar AD
J Assoc Physicians India; 2000 Nov; 48(11):1064-9. PubMed ID: 11310382
[TBL] [Abstract][Full Text] [Related]
13. Histological features of acute viral hepatitis.
Poulsen H
Ann Clin Res; 1976 Jun; 8(3):139-50. PubMed ID: 793496
[TBL] [Abstract][Full Text] [Related]
14. Relationship of serum alpha-fetoprotein to the severity and duration of illness in patients with viral hepatitis.
Bloomer JR; Waldmann TA; McIntire R; Klatskin G
Gastroenterology; 1975 Feb; 68(2):342-50. PubMed ID: 163780
[TBL] [Abstract][Full Text] [Related]
15. [Relation of serological markers of hepatitis B virus and alanine transaminase to hepatic tissue pathology in patients with chronic hepatitis B].
Yang XY; Wen FY; Wu JL; Zhou HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):892-3. PubMed ID: 16793626
[TBL] [Abstract][Full Text] [Related]
16. [Gamma globulin therapy of acute viral hepatitis. Studies on the therapeutic effect of gamma globulin on the course and late prognosis of manifested acute viral hepatitis in man].
Eisenburg J; Meister P; Holl J; Grunst J
Fortschr Med; 1975 Aug; 93(24):1085-91. PubMed ID: 57914
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
19. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.
Gordon SC; Elloway RS; Long JC; Dmuchowski CF
Hepatology; 1993 Dec; 18(6):1338-43. PubMed ID: 8244258
[TBL] [Abstract][Full Text] [Related]
20. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
